StockDuty ← Dashboard Sep 08, 2026 07:54 PM ET
SignalCorporate

$TNXP (TONIX PHARMACEUTICALS HOLDING) — 8-K: Tonix promotes Thomas Englese to Chief Commercial Officer amid TONMYA U.S. launch

TNXP
$3.01
-7.10%
Tonix Pharmaceuticals promoted Thomas Englese, MBA, to Chief Commercial Officer, effective immediately. He has led commercial operations since September 2024, including the go-to-market strategy and U.S. launch of TONMYA for fibromyalgia in adults. Englese will continue directing sales, marketing, market access, and commercial operations for TONMYA, Zembrace SymTouch, and Tosymra.
Tonix Pharmaceuticals promoted Thomas Englese, MBA, to Chief Commercial Officer, effective immediately. He has led commercial operations since September 2024, including the go-to-market strategy and U
Sources